Recent Quotes (30 days)

You have no recent quotes
chg | %

Cynapsus Therapeutics Inc  

(Public, CVE:CTH)   Watch this stock  
Find more results for CTH
1.24
Nov 27 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.38 - 1.51
Open     -
Vol / Avg. 0.00/303,419.00
Mkt cap 98.66M
P/E     -
Div/yield     -
EPS -0.14
Shares 79.56M
Beta 0.81
Inst. own     -
Jul 19, 2016
Cynapsus Therapeutics Inc Analyst and Investor Day
  

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -45.54% -46.11%
Return on average equity -47.97% -49.53%
Employees 25 -
CDP Score - -

Address

828 Richmond St W
TORONTO, ON M6J 1C9
Canada
+1-416-7032449 (Phone)
+1-416-7038752 (Fax)

Description

Cynapsus Therapeutics Inc is a Canada-based central nervous system (CNS) pharmaceutical company. It develops a thin film for the potential treatment for on-demand management of debilitating OFF episodes associated with Parkinson’s disease (PD). Its product candidate is APL-130277, a sublingual formulation of apomorphine hydrochloride.